PAI Life Sciences specializes in the developmental and translational research necessary to bring products from the laboratory through the clinical bedside on to commercialization.
We started as Protein Advances Incorporated in 2004, and today PAI has the lab facilities and the scientific expertise available to pursue a deployment-driven approach to vaccine and diagnostic discovery, process development, and product prototyping.
At its inception, PAI developed a computational methodology harnessing the power of cloud computing to represent the proteome of a pathogenic organism by a small number of peptide pools, a method that enabled rapid and economical screening of an entire proteome and thereby provided a valuable utility in the quest for new diagnostic, vaccine, and therapeutic targets. In addition to the bioinformatics approach, PAI has developed a number of biotech candidates in the last ten years. The wet lab capabilities of the company are used to move partnered projects and antigenic leads forward to translation to the clinical bedside.
We have developed candidates in the therapeutic, device, vaccine and diagnostic market and two products that we had developed are in the market now.
As part of our research we are developing protein-based antigens and therapeutics and have a pipeline of products ranging from infectious disease vaccines and adjuvants to small molecule therapeutics.
Fully-equipped Lab Facilities
The PAI facilities are designed for molecular, immunological, and chemical research and contain a wide variety of standard equipment for general use including laminar flow hoods, tissue culture incubators, fume hoods, water purification system, ice machine, balances, ovens, pH meters, vacuum oven, and a wide variety of small equipment.
Additionally, PAI has access to a complete chemistry laboratory facility located in the same building. In addition to fume hoods, rotary evaporators, and glassware, we are able to use major equipment including a Bruker Avance 300 MHz NMR spectrometer, Agilent 1100 LCMS, preparative HPLC systems, automatic flash chromatography system, hydrogenator, and ozone generator.
Meet the PAI Team
Darrick Carter, Ph.D.
CEO
Ruth Havertz, M.Sc.
Head of Operations
Sean Gray, Ph.D.
VP Research & Development
Jenn Davis, MT, CLS
Scientist
Jiho Kim, Ph.D. MPH
Scientist